Medtronic, Stryker, Boston Scientific, Intuitive Surgical, Abbott Labs. Switching costs + regulatory + brand moats compound in surgical instruments + implantable devices - the original 'razor-blade' healthcare model.
Industry leader
Synektik S.A. SNT.WA
Buffett-Fit: 64/100
Medical devices compound through surgeon training + hospital purchasing relationships + FDA-approved product cycles. Once a surgeon is trained on a specific implant or surgical robot, switching costs are real - retraining, recertification, and surgeon preference all favour the incumbent. Look for ROIC above 15% + gross margins above 60%.
Sorted by composite quality score - ROIC, margin stability, balance-sheet strength, growth quality. Click any ticker for the full Buffett verdict.
2.3B mcap
1.7B mcap
28.5B mcap
1.2B mcap
94.8B mcap
15.9B mcap
12.5B mcap
71.8B mcap
117.0B mcap
11.1B mcap
150.4B mcap
2.3B mcap
12.6B mcap
149.1B mcap
49.8B mcap
10.0B mcap
555M mcap
1.2B mcap
847M mcap
20.9B mcap
12.5B mcap
9.3B mcap
3.0B mcap
1.1B mcap
8.4B mcap
637M mcap
25.1B mcap
625M mcap
1.1B mcap
4.1B mcap
577M mcap
9.0B mcap
564M mcap
2.1B mcap
789M mcap
748M mcap
1.5B mcap
700M mcap
1.4B mcap
3.7B mcap
1.2B mcap
1.2B mcap
839M mcap
609M mcap
1.2B mcap
1.2B mcap
541M mcap
1.3B mcap
2.1B mcap
6.1B mcap
See all industries + sector-level statistics + framework filters.
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.